Randomized Phase III Trial of Sequential Adjuvant Chemoradiotherapy With or Without Erythropoietin Alfa in Patients With High-Risk Cervical Cancer: Results of the NOGGO-AGO Intergroup Study Although ...
A gene that stops the development of ovarian cancer and which could pave the way for the development of new drugs against the deadly disease has been discovered. In nearly 90% of the ovarian tumours ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results